Comprehensive bioinformatic analysis identifies potential therapeutic drugs for CryAB (R120G)-related cardiomyopathy. [PDF]
Zheng J +5 more
europepmc +1 more source
Role of voltage-gated chloride channels in epilepsy: current insights and future directions. [PDF]
Ni MM, Sun JY, Li ZQ, Qiu JC, Wu CF.
europepmc +1 more source
Delpacibart etedesiran improves the molecular pathology of myotonic dystrophy type 1 in the phase 1/2 MARINA study. [PDF]
Kwan TT +11 more
europepmc +1 more source
Myotonia: Recognition, Evaluation, and Differential Diagnosis. [PDF]
Crayle JI, Al-Lozi M, Miller TM.
europepmc +1 more source
Severe Adult-Onset Non-Dystrophic Myotonia With Apnea and Laryngospasm Due to Digenic Inheritance of SCN4A and CLCN1 Variants: A Case Report. [PDF]
Tugizova M +6 more
europepmc +1 more source
Treatment updates in myotonic disorders. [PDF]
Matthews E, Specterman MJ, Mul K.
europepmc +1 more source
Modified Polycyclic Compounds Rescue Mis-splicing in Myotonic Dystrophy Type 1 Disease Models. [PDF]
Frias JA +22 more
europepmc +1 more source
Introduction/Aims: Myotonia congenita (MC) is the most common hereditary channelopathy in humans. Characterized by muscle stiffness, MC may be transmitted as either an autosomal dominant (Thomsen) or a recessive (Becker) disorder.
Traeger-Synodinos, Joanne +12 more
core
Analysis of the differential transcriptome expression profiles during prenatal muscle tissue development in Diqing Tibetan pigs. [PDF]
Luo S +5 more
europepmc +1 more source
Differential pathology and susceptibility to MBNL loss across muscles in myotonic dystrophy mouse models. [PDF]
Davenport ML +5 more
europepmc +1 more source

